This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Loyal L. Conrad, MD

Arch Intern Med. 1966;118(3):274.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor:

When the many published reports on the efficacy of long-term anticoagulant therapy in preventing recurrences of myocardial infarction are studied, one cannot fail but to be impressed by a curious phenomenon: that as experimental design has become more and more rigorous, the documentation of the benefits derived from this particular form of therapy have become more and more difficult as the differences between control and treated patients tend to vanish Thus, in Bjerklund's study and in the British Medical Research Council Study, the probability value for successful therapy in males of the most favorable category (selected by age) calculates to be about 0.1 (at times, slightly less, but never at the 0.05 level). When control of observer bias is added as well to the experimental design, as was done by Seaman and by our group using the double-blind placebo technique, no benefit from anticoagulant therapy was demonstrated . . . [Full Text PDF of this Article]

Author Affiliations
Cardiovascular Disease Section Veterans Administration Hospital Oklahoma City

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?